Globalization has broadened opportunities for companies to make their products available to more people in more markets, while at the same time ensuring patients in emerging markets have access to products that can change or even save lives.
As regulatory authorities look at expanding collaborative efforts and as emerging markets continue to modernize and evolve, companies will gain new opportunities – and new challenges. Understanding and planning for these market dynamics – at a global, regional and local level – will be key to successfully bringing new products to market and taking established products into new markets.